A Role for EZH2 in Silencing of IFN-gamma Inducible MHC2TA Transcription in Uveal Melanoma
Overview
Authors
Affiliations
We investigated the contribution of epigenetic mechanisms in MHC2TA transcriptional silencing in uveal melanoma. Although no correlation was observed between impaired CIITA transcript levels after IFN-gamma induction and DNA methylation of MHC2TA promoter IV (CIITA-PIV), an association was found with high levels of trimethylated histone H3-lysine 27 (3Me-K27-H3) in CIITA-PIV chromatin. The 3Me-K27-H3 modification correlated with a strong reduction in RNA polymerase II-recruitment to CIITA-PIV. Interestingly, we observed that none of these epigenetic modifications affected recruitment of activating transcription factors to this promoter. Subsequently, we demonstrated the presence of the histone methyltransferase EZH2 in CIITA-PIV chromatin, which is known to be a component of the Polycomb repressive complex 2 and able to triple methylate histone H3-lysine 27. RNA interference-mediated down-regulation of EZH2 expression resulted in an increase in CIITA transcript levels after IFN-gamma induction. Our data therefore reveal that EZH2 contributes to silencing of IFN-gamma-inducible transcription of MHC2TA in uveal melanoma cells.
Biological characteristics and clinical management of uveal and conjunctival melanoma.
Kastelan S, Didovic Pavicic A, Pasalic D, Nikuseva-Martic T, canovic S, Kovacevic P Oncol Res. 2024; 32(8):1265-1285.
PMID: 39055896 PMC: 11267116. DOI: 10.32604/or.2024.048437.
Wang B, Liu Y, Xiong F, Wang C Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931345 PMC: 11206763. DOI: 10.3390/ph17060678.
EHMT2 promotes tumorigenesis in -mutant uveal melanoma ARHGAP29-mediated RhoA pathway.
Li Y, Zhu T, Yang J, Zhang Q, Xu S, Ge S Acta Pharm Sin B. 2024; 14(3):1187-1203.
PMID: 38486999 PMC: 10935147. DOI: 10.1016/j.apsb.2023.12.002.
Herwig-Carl M, Sharma A, Tischler V, Pelusi N, Loeffler K, Holz F Invest Ophthalmol Vis Sci. 2024; 65(2):27.
PMID: 38349785 PMC: 10868634. DOI: 10.1167/iovs.65.2.27.
Pickles O, Wanigasooriya K, Ptasinska A, Patel A, Robbins H, Bryer C Cancer Res Commun. 2023; 3(8):1501-1513.
PMID: 37565053 PMC: 10411481. DOI: 10.1158/2767-9764.CRC-23-0091.